Niva Bupa Health Insurance Company Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.4 pts more than Nifty Smallcap 250 and 3.6 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niva Bupa faced a GST demand of about ₹1,241.30 million (roughly ₹124 crore) from the Principal Commissioner CGST for non-payment of GST on co-insurance premium (₹2.78 million) and reinsurance commission (₹1,238.52 million) covering July 2017 to March 2022. The company had challenged this order through a writ petition before the Bombay High Court. In a favorable ruling on July 3, 2025, the High Court set aside the demand order and sent the matter back to the Adjudicating authority for a fresh hearing. Niva Bupa noted this is an industry-wide issue and stated there are no immediate financial implications.
Positive for shareholders — the court ruling overturns a significant demand order against the company, reducing near-term liability risk. However, the matter remains open as it has been remanded for reconsideration, so the final outcome is still uncertain.